2022年12月8日 Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
2022年11月7日 Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
2022年10月19日 Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions